- Home
- BLRX vs JFU Comparison
BLRX vs JFU Comparison
Compare BLRX & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- JFU
- Stock Information
- Founded
- BLRX 2003
- JFU 2006
- Country
- BLRX Israel
- JFU China
- Employees
- BLRX N/A
- JFU N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- BLRX Health Care
- JFU Finance
- Exchange
- BLRX Nasdaq
- JFU Nasdaq
- Market Cap
- BLRX 17.1M
- JFU 17.1M
- IPO Year
- BLRX 2011
- JFU 2019
- Fundamental
- Price
- BLRX $3.50
- JFU $4.86
- Analyst Decision
- BLRX Strong Buy
- JFU
- Analyst Count
- BLRX 2
- JFU 0
- Target Price
- BLRX $19.00
- JFU N/A
- AVG Volume (30 Days)
- BLRX 29.2K
- JFU 148.6K
- Earning Date
- BLRX 11-24-2025
- JFU 12-09-2022
- Dividend Yield
- BLRX N/A
- JFU N/A
- EPS Growth
- BLRX N/A
- JFU 3110.57
- EPS
- BLRX N/A
- JFU 3.04
- Revenue
- BLRX $17,251,000.00
- JFU $44,573,690.00
- Revenue This Year
- BLRX N/A
- JFU N/A
- Revenue Next Year
- BLRX N/A
- JFU N/A
- P/E Ratio
- BLRX N/A
- JFU $1.62
- Revenue Growth
- BLRX 1.19
- JFU 8.19
- 52 Week Low
- BLRX $2.30
- JFU $1.01
- 52 Week High
- BLRX $22.60
- JFU $5.88
- Technical
- Relative Strength Index (RSI)
- BLRX 37.77
- JFU 62.70
- Support Level
- BLRX $3.51
- JFU $4.70
- Resistance Level
- BLRX $3.89
- JFU $5.37
- Average True Range (ATR)
- BLRX 0.24
- JFU 0.66
- MACD
- BLRX -0.04
- JFU -0.01
- Stochastic Oscillator
- BLRX 0.00
- JFU 53.23
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.